Paradigm Biopharmaceuticals Ltd. announced that independent Non Executive Director Mr. John Gaffney has resigned, effective immediately. After serving on the Paradigm Board for over 9 years, John is now looking to focus on his other roles. Non-Executive Director Amos Meltzer will assume the role of Chair of the Company's Remuneration and Nomination Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.25 AUD | 0.00% | -1.96% | -41.18% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.18% | 58.16M | |
+46.55% | 54.63B | |
-6.91% | 39.92B | |
+37.07% | 38.82B | |
+13.17% | 26.86B | |
-11.17% | 26.22B | |
-21.98% | 18.78B | |
+25.15% | 12.21B | |
+0.54% | 12.16B | |
+25.14% | 11.94B |
- Stock Market
- Equities
- PAR Stock
- News Paradigm Biopharmaceuticals Limited
- Paradigm Biopharmaceuticals Ltd Announces Resignation of John Gaffney as Independent Non Executive Director, Effective Immediately